Donor-derived Cell-free DNA as a Noninvasive Biomarker of Kidney Allograft Rejection in Pediatric Kidney Transplantation
dd-cfDNA combined with standard of care improves the prediction of rejection in pKTRs. Further specific studies are needed to better define how to use this promising biomarker in various contexts of use in children.
Authors
- Élodie Cheyssac
- Charlotte Duneton (ORCID: https://orcid.org/0000-0002-0603-1970)
- Carissa Hayes
- Chris Fan (ORCID: https://orcid.org/0000-0003-1866-3964)
- Olivier Aubert (ORCID: https://orcid.org/0000-0001-8204-1567)
- Julien Hogan (ORCID: https://orcid.org/0000-0003-4838-9417)
- Margret Kamel (ORCID: https://orcid.org/0000-0003-4126-0493)
- Alexandre Loupy (ORCID: https://orcid.org/0000-0003-3388-7747)
- Marion Rabant (ORCID: https://orcid.org/0000-0001-5696-6478)
- Roshan George (ORCID: https://orcid.org/0000-0003-3853-967X)
- Hong Yin (ORCID: https://orcid.org/0000-0002-5215-1455)
- Rouba Garro (ORCID: https://orcid.org/0000-0003-2936-3676)
- Véronique Baudouin (ORCID: https://orcid.org/0000-0003-0242-1936)
Institutions
- Emory University (US)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Robert-Debré (FR)
Publication Details
- Journal
- Transplantation
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1097/tp.0000000000005403
- Citations
- 2
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.97